Gene expression changes caused by the p38 MAPK inhibitor dilmapimod in COPD patients: analysis of blood and sputum samples from a randomized, placebo-controlled clinical trial. - Betts, Joanna C.; Mayer, Ruth J.; Tal ‐ Singer, Ruth; Warnock, Linda; Clayton, Chris; Bates, Stewart; Hoffman, Bryan E.; Larminie, Christopher; Singh, Dave (Pharmacology Research & Perspectives, 2015)